ANIP vs TRLV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ANIP · ANI Pharmaceuticals$67.41 ▼ 3.17%
TRLV · Trulieve Cannabis$11.56 ▲ 6.06%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ANIP -24.2%
- TRLV +57.1%
Head to head
| Metric | ANIP | TRLV |
|---|---|---|
| Price | $67.41 | $11.56 |
| Change today | ▼ 3.17% | ▲ 6.06% |
| Market cap | $1.53B | $2.23B |
| Return, 3 months | -11.0% | +27.3% |
| Return, year to date | -14.6% | +33.0% |
| Return, 1 year | -25.5% | +76.5% |
| P/E (TTM) | 13.4 | – |
| P/B | 2.4 | 2.9 |
| P/E percentile vs own 5y | 62nd | 47th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +25.9% | -10.3% |
| Net profit growth (YoY) | +189.1% | -2,420.4% |
| Gross margin | 60.4% | 59.5% |
| Operating margin | 13.3% | 11.5% |
| Net margin | 10.2% | -41.6% |
| Return on equity | 19.3% | -47.5% |
| Analyst target vs. price | +55.6% | +62.2% |
| Analyst buy share | 71% | 100% |
| RSI (14) | 35 | 57 |
| 30-day volatility | 27.8% | 63.3% |
| Max drawdown, 1 year | -28.7% | -54.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TRLV is the largest of the group by market value.
- TRLV has returned the most over the past year.
- ANIP is growing revenue fastest.
- ANIP keeps the most profit per dollar of sales.
- ANIP has been the calmest stock over the last 30 days.